The agency’s 2023 decision to place 19 peptides on the “unsafe” list was supported by numerous documented safety concerns, ...

As patents on semaglutide expire, manufacturers are poised to introduce cheaper generic versions of blockbuster drugs, with far-reaching effects on the obesity crisis. Megan Tatum reports.

This new tablet promises to be even more convenient than its predecessor with similar, if slightly less drastic, ...

The FDA on approved Eli Lilly's weight-loss pill, setting ​up its next battle with rival Novo Nordisk for the millions of ...

The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form ...

The U.S. Food and Drug Administration has approved Eli Lilly's oral weight-loss drug, orforglipron, branded as Foundayo, ...

Jane Ryde says her husband would have been "horrified" by his impulsive behaviour, caused by his Parkinson's medication ...

Learn expert tips on preparing for the conversation, explaining disease progression, and discussing legal and financial plans to ensure that your wishes are met.

Cohen says he looked at around two dozen companies since Acorda wound down. Oryon Cell Therapies, with its funding, data and ...

Serina Therapeutics Inc. has alleviated immediate financial pressures through a private placement that could provide up to $30 million. The capital infusion is vital for the clinical development of ...

Add Yahoo as a preferred source to see more of our stories on Google. Professor Stephen Wallace harvesting engineered bacteria for analysis. (CREDIT: Edinburgh Innovations) Plastic waste is becoming ...